The expression of interleukin-23 (p19/p40) and inteleukin-12 (p35/p40) in psoriasis skin

Abstract

In order to investigate the mRNA expression and function of interleukin-23 (p19/p40) and interleukin-12 (p35/p40) in the psoriatic lesion, no-lesion and normal human skin, reverse transcriptase-polymerase chain reaction (RT-PCR) was used to detect the expression of IL-23 (p19/p40) and IL-12 (p35/p40). The results showed that the expression of IL-23p19 mRNA and p40 (IL-12/IL-23) mRNA were higher in psoriatic lesion than those of non-lesional skin and normal skin. The levels of IL-23p19 mRNA and p40 (IL-12/IL-23) mRNA were higher in psoriatic non-lesional skin than normal skin. However, no significant difference was found in the level of IL-12p35 mRNA among the psoriatic lesional skin, non-lesional skin and normal skin. It was suggested that IL-23 might be more important in the pathogenesis of psoriasis than IL-12.

Keywords

psoriasis / IL-23p19 / IL-23/IL-12p40 / IL-12 p35

References

[1] BrombacherF., KasteleinR. A., AlberG.. Novel IL-12 family members shed light on the orchestration of Th1 responses. TRENDS, 2003, 24(4): 207

[2] IwakuraY., IshiqameH.. The IL-23/IL-17 axis in inflammation. J Clin Invest, 2006, 116(5): 1218

[3] CuaD.J., SherlockJ., ChenY., et al.. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature, 2003, 421: 744

[4] YanoS., KomineM., FujimotoM., et al.. Interleukin 15 induces the signals of epidermal proliferation through ERK and PI3-kinase in a human epidermal keratinocyte cell line, HaCaT. Biochem Biophys Res Commun, 2003, 301(4): 841

[5] KoppT., LenzP., Bello-FernandezC., et al.. IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14/p40 transgenic mice: evidence for enhanced cutaneous immunity. J Immunol, 2003, 170(11): 5438

[6] WiekowskiM. T., LeachM. W., EvansE. W., et al.. Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. J Immunol, 2001, 166(12): 7563

[7] PiskinG., TursenU., Sylva-SteenlandR. M., et al.. Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers — IL-12, IL-18 and IL-23. Exp Dermatol, 2004, 13(12): 764

[8] ChamianF., LowesM. A., LinS. L., et al.. Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris. Proc Natl Acad Sci USA, 2005, 102(6): 2075

[9] ParhamC., ChiricaM., TimansJ., et al.. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbetal and a novel cytokine receptor subunit, IL-23R. J Immunol, 2002, 168(11): 5699

[10] LangrishC. L., ChenY., BlumenscheinW. M., et al.. IL-23 drives a pathogenic T cell population that induces auto-immune inflammation. J Exp Med, 2005, 201(2): 233